2022 American Causal Inference Conference

2022 American Causal Inference Conference

Thank you!

Background image: Shot of a glass office building, Berkeley Way West, on a sunny day.
Image credit:
Maxim Kraft

Thank you all for participating in ACIC 2022 here at UC Berkeley 

If you couldn't get enough of ACIC this year, ACIC 2023 will be held in Austin Texas, so mark your calendars for next May. Again, thank you all so much for being a part of this conference, and we hope to see you again for ACIC 2023.

The 2022 American Causal Inference Conference (ACIC) had a total of nearly 700 attendees both in-person and virtually, making this year's ACIC the largest ever! ACIC 2022 had over 140 poster presenters, 63 oral presenters, 21 sessions, and 17 teams who submitted to the ACIC data challenge session.

Useful Links

About the Sponsors

The Center for Targeted Machine Learning and Causal Inference (CTML) at UC Berkeley is an interdisciplinary research center for advancing, implementing and disseminating statistical methodology to address problems arising in public health and clinical medicine. CTML brings the rigor and power of statistical theory together with advances in machine learning and causal inference to generate robust evidence for advancing health. 

Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world’s toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines, helping make people’s lives easier, fuller and longer.

The American Statistical Association (ASA) is the world’s largest community of statisticians, the “Big Tent for Statistics.” It is the second-oldest, continuously operating professional association in the country. Since it was founded in Boston in 1839, the ASA has supported excellence in the development, application, and dissemination of statistical science through the following: meetings, member services, education, publications, advocacy, & accreditation. 

Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. The life-changing scientific breakthroughs Genentech has delivered over the last five decades stand as a testament to this patient-first philosophy.

Northeastern University is renowned for its experiential learning model, high-impact research, deep partnerships, and worldwide reach. From day one, Northeastern pursued innovative ways of teaching and research that place a premium on experience and engagement with the world. Today, its signature approach erases traditional boundaries, empowering not only students, but faculty, alumni, partners, and innovators to solve problems and pursue impact. 

Novo Nordisk's approach reflects the way we balance scientific excellence with compassion, stay rooted in our Danish heritage while making a global impact, and remain ambitious while always putting people first.

Pfizer's purpose is breakthroughs that change patients’ lives. We pursue that goal relentlessly and innovate every day to make the world a healthier place.